State of Wyoming Takes Position in IPG Photonics Corporation $IPGP

State of Wyoming bought a new position in shares of IPG Photonics Corporation (NASDAQ:IPGP) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 8,823 shares of the semiconductor company’s stock, valued at approximately $1,035,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund lifted its position in shares of IPG Photonics by 2.0% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 5,139 shares of the semiconductor company’s stock valued at $589,000 after buying an additional 100 shares in the last quarter. State of Michigan Retirement System increased its holdings in IPG Photonics by 1.7% in the 1st quarter. State of Michigan Retirement System now owns 6,100 shares of the semiconductor company’s stock worth $699,000 after acquiring an additional 100 shares in the last quarter. Assetmark Inc. raised its position in IPG Photonics by 6.8% during the fourth quarter. Assetmark Inc. now owns 1,820 shares of the semiconductor company’s stock worth $130,000 after acquiring an additional 116 shares during the period. Deutsche Bank AG raised its position in IPG Photonics by 6.1% during the fourth quarter. Deutsche Bank AG now owns 2,214 shares of the semiconductor company’s stock worth $159,000 after acquiring an additional 128 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in IPG Photonics by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 915 shares of the semiconductor company’s stock valued at $105,000 after purchasing an additional 133 shares in the last quarter. Hedge funds and other institutional investors own 93.79% of the company’s stock.

IPG Photonics Stock Performance

Shares of IPGP stock opened at $85.79 on Friday. The firm has a market cap of $3.65 billion, a P/E ratio of 131.99, a P/E/G ratio of 2.32 and a beta of 0.96. The firm’s 50 day moving average price is $101.42 and its 200-day moving average price is $111.73. IPG Photonics Corporation has a one year low of $71.38 and a one year high of $155.82.

IPG Photonics (NASDAQ:IPGP) last posted its earnings results on Tuesday, August 4th. The semiconductor company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.21. The firm had revenue of $278.58 million during the quarter, compared to the consensus estimate of $279.98 million. IPG Photonics had a net margin of 2.58% and a return on equity of 3.39%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.16 EPS. IPG Photonics has set its Q3 2026 guidance at 0.300-0.600 EPS. As a group, research analysts predict that IPG Photonics Corporation will post 1.78 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently issued reports on IPGP shares. Wall Street Zen lowered shares of IPG Photonics from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Needham & Company LLC upped their price target on shares of IPG Photonics from $110.00 to $120.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of IPG Photonics in a research note on Wednesday, June 24th. Stifel Nicolaus lowered their price objective on IPG Photonics from $165.00 to $125.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Finally, Zacks Research lowered IPG Photonics from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 4th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $142.60.

Insider Buying and Selling at IPG Photonics

In other news, Director Eugene A. Scherbakov sold 1,524 shares of IPG Photonics stock in a transaction on Friday, July 31st. The stock was sold at an average price of $86.61, for a total value of $131,993.64. Following the completion of the sale, the director directly owned 48,210 shares of the company’s stock, valued at approximately $4,175,468.10. The trade was a 3.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Fibre Devices Ltd Ip sold 65,700 shares of IPG Photonics stock in a transaction on Monday, June 29th. The shares were sold at an average price of $103.64, for a total value of $6,809,148.00. Following the completion of the sale, the insider directly owned 6,463,302 shares of the company’s stock, valued at $669,856,619.28. The trade was a 1.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 193,863 shares of company stock valued at $19,449,856. Corporate insiders own 37.50% of the company’s stock.

IPG Photonics Company Profile

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.